X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-02-16 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | A - Grant | $0.00 | +16,980 | 35,697 | +91% | +$0 | ||||||
2024-02-16 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | F - Tax | $308.55 | -6,212 | 35,697 | -15% | -$1,916,713 | ||||||
| D | 2024-01-31 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | G - Gift | $0.00 | -728 | 24,929 | -3% | -$0 | |||||
| D | 2024-01-31 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | S - Sale+OE | $306.79 | -3,200 | 24,929 | -11% | -$981,734 | |||||
2023-04-28 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | S - Sale | $284.44 | -12,556 | 28,783 | -30% | -$3,571,396 | ||||||
| D | 2023-04-24 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | M - OptEx | $101.16 | +32,020 | 41,339 | +344% | +$3,239,143 | |||||
| D | 2023-04-24 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | F - Tax | $286.25 | -19,464 | 41,339 | -32% | -$5,571,570 | |||||
2023-02-17 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | A - Grant | $0.00 | +12,160 | 28,751 | +73% | +$0 | ||||||
2023-02-17 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | F - Tax | $262.84 | -4,232 | 28,751 | -13% | -$1,112,339 | ||||||
| D | 2022-10-31 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | G - Gift | $0.00 | -450 | 20,823 | -2% | -$0 | |||||
| D | 2023-02-01 | HCA | Cuffe Michael S. | EVP, Chief Clinical Officer | S - Sale+OE | $257.11 | -4,000 | 20,823 | -16% | -$1,028,440 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |